Detalhe da pesquisa
1.
Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.
Acta Derm Venereol
; 99(2): 206-210, 2019 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393817
2.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Eur Respir J
; 50(2)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28798088
3.
ICU admission for solid cancer patients treated with immune checkpoint inhibitors.
Ann Intensive Care
; 13(1): 29, 2023 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072645
4.
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer Patients.
Clin Lung Cancer
; 21(5): e497-e510, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32605892
5.
Management of pulmonary toxicity associated with immune checkpoint inhibitors.
Eur Respir Rev
; 28(154)2019 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694838
6.
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
Lung Cancer
; 137: 1-6, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518912
7.
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab.
Lung Cancer
; 120: 108-112, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748004
8.
Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma.
Oncotarget
; 8(23): 38056-38060, 2017 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445137
9.
Targeting the immune system to treat lung cancer: rationale and clinical experience.
Ther Adv Respir Dis
; 9(3): 105-20, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827132